Patents by Inventor Harry Fisch

Harry Fisch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080009468
    Abstract: A method for reducing an antigen indicator of prostate cancer and for reducing the need for biopsies in men suspected of having prostate cancer and a method for treating patients with elevated PSA levels. In one method, the level of an antigen indicator of prostate cancer is measured and for an above normal level of the antigen indicator, an effective amount of an anti-inflammatory, or a combination of the anti-inflammatory and an antibiotic, is administered and the level of the antigen indicator is remeasured to determine if the level is normal or reduced, whereby a biopsy may not be indicated.
    Type: Application
    Filed: September 21, 2007
    Publication date: January 10, 2008
    Inventor: HARRY FISCH
  • Patent number: 7067557
    Abstract: The administration of antiestrogens to men suffering a relative androgen deficiency stimulates the body's production of testosterone leading to a correction of the deficiency. For example, male menopause, loss of cognitive function, insulin resistance, type 2 diabetes, obesity, excessive weight, Alzheimer's disease, and combinations thereof, can all be characterized by significant decreases in serum levels of bioavailable androgens. Administration of antiestrogens to men restores optimum serum levels of bioavailable androgens, and, thus, serves as a treatment for these disorders and relative androgen deficiency in general.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: June 27, 2006
    Inventor: Harry Fisch
  • Publication number: 20040043970
    Abstract: A method for reducing an antigen indicator of prostate cancer and for reducing the need for biopsies in men suspected of having prostate cancer and a method for treating patients with elevated PSA levels. In one method, the level of an antigen indicator of prostate cancer is measured and for an above normal level of the antigen indicator, an effective amount of an anti-inflammatory, or a combination of the anti-inflammatory and an antibiotic, is administered and the level of the antigen indicator is remeasured to determine if the level is normal or reduced, whereby a biopsy may not be indicated.
    Type: Application
    Filed: March 21, 2003
    Publication date: March 4, 2004
    Inventor: Harry Fisch
  • Publication number: 20020120012
    Abstract: The administration of antiestrogens to men suffering a relative androgen deficiency stimulates the body's production of testosterone leading to a correction of the deficiency. For example, male menopause, loss of cognitive function, insulin resistance, type 2 diabetes, obesity, excessive weight, Alzheimer's disease, and combinations thereof, can all be characterized by significant decreases in serum levels of bioavailable androgens. Administration of antiestrogens to men restores optimum serum levels of bioavailable androgens, and, thus, serves as a treatment for these disorders and relative androgen deficiency in general.
    Type: Application
    Filed: February 21, 2002
    Publication date: August 29, 2002
    Inventor: Harry Fisch
  • Patent number: 6391920
    Abstract: Male menopause is characterized by significant decreases in serum levels of bioavailable androgens. The administration of antiestrogens to men experiencing male menopause can remedy the relative androgen deficiency in men by stimulating the body's production of testosterone.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: May 21, 2002
    Inventor: Harry Fisch
  • Patent number: 5349436
    Abstract: A biological assembly for effecting the examination of a sample in a liquid medium under magnification. The assembly includes a transparent slide with a sample chamber and an immediately adjacent overflow chamber formed on one main surface by a thin film. The sample chamber is receptive of a sample in a liquid medium. transparent slide, having a pattern for aligning it with the sample chamber, is disposed over the sample chamber. The transparent slide includes a grid etched into the lower surface thereof to enable the counting of cells under magnification.
    Type: Grant
    Filed: December 2, 1992
    Date of Patent: September 20, 1994
    Inventor: Harry Fisch
  • Patent number: RE35589
    Abstract: A biological assembly for effecting the examination of a sample in a liquid medium under magnification. The assembly includes a transparent slide with a sample chamber and an immediately adjacent overflow chamber formed on one main surface by a thin film. The sample chamber is receptive of a sample in a liquid medium. transparent slide, having a pattern for aligning it with the sample chamber, is disposed over the sample chamber. The transparent slide includes a grid etched into the lower surface thereof to enable the counting cells under magnification.
    Type: Grant
    Filed: August 29, 1995
    Date of Patent: August 19, 1997
    Inventor: Harry Fisch
  • Patent number: D418228
    Type: Grant
    Filed: September 3, 1998
    Date of Patent: December 28, 1999
    Inventor: Harry Fisch
  • Patent number: D423678
    Type: Grant
    Filed: May 26, 1999
    Date of Patent: April 25, 2000
    Inventor: Harry Fisch
  • Patent number: D431300
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: September 26, 2000
    Inventor: Harry Fisch
  • Patent number: D431301
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: September 26, 2000
    Inventor: Harry Fisch